How AI is streamlining patient access, speeding diagnostics, and powering personalized treatments for better outcomes across health systems.
AI Healthcare’s Latest Strides: Driving Efficiency and Innovation in Patient Care Read More »
How AI is changing diagnostics: benefits in radiology and pathology, risks like bias and automation bias, and practical steps for safe, clinician-centered adoption.
AI in Diagnostics: Progress, Challenges, and Responsible Integration Read More »
A concise, expert brief on how AI is reshaping diagnostics in radiology and pathology, its measurable benefits, main risks, and a practical governance roadmap.
AI in Healthcare Diagnostics: Practical Guide for Clinicians and Leaders Read More »
New AI-driven CSF liquid biopsy reads DNA methylation with M-PACT to identify brain tumors noninvasively. High accuracy, strong potential for pediatric care.
AI-Powered CSF Liquid Biopsy for Brain Tumors: M-PACT Breakthrough Read More »
Explore how AI can transform NHS patient access, strengthen cybersecurity, and power preventive health and workforce support across the UK health system.
AI in UK Healthcare: Solving Digital Access, Cyber Risk and Preventive Care Gaps Read More »
AI in drug discovery is set to grow 25-30% over five years. Read a concise briefing on drivers, key applications like oncology, major innovations and remaining hurdles.
AI in Drug Discovery: Trends, Partnerships and the Road Ahead Read More »
A concise expert digest on recent healthcare developments and practical AI applications across primary care, finance, integrated delivery, pharma and sustainable investments.
AI in Healthcare: Strategic Responses to Recent Sector Shifts Read More »
Agentic AI forms collaborative in silico teams that speed drug discovery, biomarker discovery and data analysis while raising validation and governance questions.
Agentic AI and In Silico Team Science: Accelerating Biomedical Research Read More »
How recent UK policy moves open the door for AI to improve primary care, screening, referral management, and personalised support while strengthening data governance.
AI in UK Healthcare: Turning Policy Shifts into Primary Care and System Gains Read More »
DeepRare, developed at Shenhua Hospital, raises rare disease diagnostic accuracy to 57% with clinical data and over 70% with genetics, offering traceable AI reasoning for clinicians worldwide.
How DeepRare Is Redefining Rare Disease Diagnosis in China and Beyond Read More »
